Rafael Holdings, Inc. (NYSE:RFL) Shares Shorted: Short Interest Down 55.9% in October

Rafael Holdings, Inc. (NYSE:RFL) was the target of a significant decrease in short interest in October. As of October 15th, there was short interest totaling 348,361 shares, a decrease of 55.9% from the September 30th total of 789,108 shares. Currently, 1.0% of the company’s stock are short sold. Based on an average daily volume of 127,973 shares, the days-to-cover ratio is presently 2.7 days.

Rafael Stock Performance

Shares of RFL traded down $0.03 during mid-day trading on Friday, reaching $1.09. The company had a trading volume of 67,242 shares, compared to its average volume of 72,806. The firm has a 50-day moving average price of $1.84 and a 200 day moving average price of $1.69. Rafael has a 52 week low of $1.08 and a 52 week high of $3.96. The company has a market capitalization of $56.94 million, a price-to-earnings ratio of -1.89 and a beta of 0.35.

Rafael (NYSE:RFL) last posted its quarterly earnings data on Thursday, October 29th. The company reported ($0.18) earnings per share for the quarter. Rafael had a negative net margin of 3,390.73% and a negative return on equity of 39.52%. The company had revenue of $0.24 million for the quarter.

Hedge Funds Weigh In On Rafael

A hedge fund recently raised its position in Rafael stock. Renaissance Technologies LLC lifted its stake in Rafael Holdings, Inc. (NYSE:RFL) by 59.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 89,138 shares of the company’s stock after purchasing an additional 33,111 shares during the quarter. Renaissance Technologies LLC owned 0.17% of Rafael worth $111,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 11.30% of the company’s stock.

Wall Street Analyst Weigh In

RFL has been the subject of several recent research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Rafael in a research report on Tuesday, August 25th. Wall Street Zen raised shares of Rafael to a “hold” rating in a research report on Saturday, July 25th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company has an average rating of “Sell”.

About Rafael

Rafael Holdings, Inc (NYSE:RFL) is a diversified holding company with interests in biotechnology and commercial real estate. Through its life sciences operations, the company has focused on developing potential treatments for cancer and other serious diseases, including therapies designed to target the metabolism of cancer cells.

Rafael’s biotechnology activities have been conducted primarily through Rafael Pharmaceuticals, which has researched investigational drug candidates such as devimistat (also known as CPI-613).